Sources and small print

1. Results are based on the SURMOUNT-1 Mounjaro trial. Results vary – weight loss can be more or less than the 21% average.

Jastreboff, A.M. et al. (2022) "Tirzepatide Once Weekly for the Treatment of Obesity" New England Journal of Medicine, 387(3)

https://doi.org/10.1056/NEJMoa2206038

* Terms and conditions apply.

** Price may increase or decrease subject to market conditions.

*** Coming soon.

**** Maximum of one consultation per week with no carry-over of unused appointments.

***** An admin fee may apply for early cancellation. See our terms and conditions.